BCL2L1 and neoplasm: Indeed, silencing Bcl-xL expression significantly increased the tumor cell sensitivity to TRAIL-induced apoptosis and overexpression of Bcl-xL significantly decreased the tumor cell sensitivity to TNFα and IFN-γ-sensitized and TRAIL-induced apoptosis.